Sort by
Neuroscience
Alpha Galactosidase
6%
Alzheimer's Disease
9%
Amyotrophic Lateral Sclerosis
48%
Anosmia
6%
Ataxia
27%
Cerebral Infarction
8%
Cognitive Disorders
20%
Delusion
6%
Diffusion MRI
6%
Diffusion Tensor Imaging
17%
Dopamine Transporter
7%
Electrical Brain Stimulation
6%
Encephalitis
6%
Encephalomyelitis
6%
Fingolimod
6%
Fractional Anisotropy
25%
Frontal Lobe
7%
Hepatic Encephalopathy
6%
Herpes
6%
Herpes Simplex Virus
6%
Leuprorelin
6%
Magnetic Resonance Angiography
6%
Magnetic Resonance Imaging
15%
Magnetic Resonance Imaging
14%
Magnetic Resonance Neurography
6%
Meningoencephalitis
6%
Multiple Sclerosis
6%
Multiple System Atrophy
100%
Muscle Atrophy
13%
Nervous System Disorder
7%
Olanzapine
6%
Parkinson's Disease
62%
Parkinsonism
8%
Progressive Muscular Atrophy
6%
Progressive Supranuclear Palsy
7%
Purine
8%
Pyramidal Tract
6%
Serotonin
8%
Serotonin Transporter
6%
Single-Photon Emission Computed Tomography
9%
Spinocerebellar Ataxia
7%
Spinocerebellar Ataxia Type-6
6%
Subthalamic Nucleus
6%
Synuclein
9%
TANK-binding Kinase 1
6%
Triggering Receptor Expressed on Myeloid Cells 2
8%
Uric Acid
6%
Vasoconstrictors
6%
Voice Disorder
6%
Voxel-Based Morphometry
8%
Medicine and Dentistry
Ageusia
6%
Alzheimer's Disease
6%
Amyotrophic Lateral Sclerosis
13%
Anhidrosis
6%
Aspergillosis
6%
Brachial Plexus Neuropathy
6%
Brain Biopsy
6%
Cognitive Defect
6%
Cohort Analysis
6%
Diagnosis
11%
Diagnostic Accuracy
6%
Diffusion MRI
6%
Diffusion Tensor Imaging
11%
Disease Duration
5%
Electrical Brain Stimulation
13%
Extramedullary Hematopoiesis
6%
Germinoma
6%
Glycine Receptor
6%
Granulomatous Inflammation
6%
Kennedy Disease
6%
Liver Transplantation
6%
Magnetic Resonance Angiography
6%
Magnetic Resonance Imaging
10%
Magnetic Resonance Neurography
6%
Meta-Analysis
6%
Myelofibrosis
6%
Myopathy
6%
Nemaline Myopathy
6%
Neurologic Disease
8%
Nicotine Patch
6%
Orthostatic Hypotension
6%
Orthostatic Stress
6%
Parkinson's Disease
13%
Parkinsonism
6%
Patient-Data
6%
Pyramidal Tract
6%
Reversible Cerebral Vasoconstriction Syndrome
6%
Sarcoidosis
6%
Shy-Drager Syndrome
13%
Six Minute Walk Test
6%
Skeletal Muscle
5%
Speech Disorder
7%
Spinocerebellar Ataxia
6%
Subthalamic Nucleus
13%
Symptom
5%
Systematic Review
6%
Triggering Receptor Expressed on Myeloid Cells 2
6%
Vasoconstrictor
6%
Voice Disorder
13%
Wilson's Disease
6%
Keyphrases
1-year Follow-up
6%
Acquired Hepatocerebral Degeneration
6%
Ageusia
6%
Amyotrophic Lateral Sclerosis
6%
Anhidrosis
6%
Autonomic nuclei
6%
Callosal
6%
Cerebello-cerebral Network
6%
COQ2
6%
Decline Type
6%
Delusions
6%
Diagnostic Errors
6%
Differential Motor
6%
Droxidopa
6%
Early Detection
13%
Extramedullary Hematopoiesis
6%
Fingolimod Therapy
6%
Hypokinetic Dysarthria
9%
Japanese Patients
6%
Laryngoscopic View
6%
Leuprorelin
6%
Magnetic Resonance Imaging Features
6%
Masquerade
6%
Monotherapy
6%
MSA-P
6%
Myelofibrosis
6%
Nemaline Myopathy
6%
Olanzapine
6%
Orbital MRI
6%
Parkinson Patients
9%
Parkinson's Disease
21%
Patients with Parkinson's Disease
6%
Radiological Impact
6%
Randomized Controlled Trial
6%
Rehabilitation Trials
6%
Repetitive Speech
6%
Reversible Cerebral Vasoconstriction Syndrome
6%
Sensory Phenotype
6%
Speech Disorders
6%
Spinal Cord Compression
6%
Subthalamic nucleus Deep Brain Stimulation (STN-DBS)
13%
Survey System
6%
TANK-binding Kinase 1 (TBK1)
6%
Temperature Sensing
6%
Type II Respiratory Failure
6%
Urinary 8-hydroxydeoxyguanosine
6%
Voice Disorders
6%
Voice Features
6%
Walking Capacity
6%
α-galactosidase
6%
